The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 31, 2016

Filed:

Jan. 29, 2008
Applicants:

Yasuo Konishi, Kirkland, CA;

Joanne Magoon, Montreal, CA;

Suwatchai Jarussophon, Montreal, CA;

Inventors:

Yasuo Konishi, Kirkland, CA;

Joanne Magoon, Montreal, CA;

Suwatchai Jarussophon, Montreal, CA;

Assignee:

National Research Council of Canada, Ottawa, Ontario, unknown;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/137 (2006.01); A61K 31/216 (2006.01); A61K 31/222 (2006.01); A61K 31/36 (2006.01); A61K 31/445 (2006.01); A61K 31/495 (2006.01); A61K 31/522 (2006.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A61K 31/216 (2013.01); A61K 31/222 (2013.01); A61K 31/36 (2013.01); A61K 31/445 (2013.01); A61K 31/495 (2013.01); A61K 31/522 (2013.01);
Abstract

A catecholamine or related compound having (S)-configuration at β-carbon, a physiologically tolerated salt thereof, a prodrug thereof, a physiologically functional derivative thereof or any mixture thereof and having a lipophilicity greater than (S)-noradrenaline has use as an anti-angiogenic agent. A catecholamine or related compound in which a β-hydroxy group has been modified are also anti-angiogenic. The anti-angiogenic agent is preferably a compound of formula (I) or (II) a physiologically tolerated salt thereof, a prodrug thereof, a physiologically functional derivative thereof or any mixture thereof.


Find Patent Forward Citations

Loading…